Market cap
$5.9b
End-of-day close multiplied by current shares on issue.
Result releasedAnnolyse analysis published
Revenue and PBT grew but a $148.5m working-capital build and a discontinued-operation loss pulled NPAT down 44.0%.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Market context
A close-dated read on what the market price implies next to the latest verified filing inputs. Unavailable metrics stay visible when the absence is useful context.
The latest close and share count context for the market price.
Market cap
$5.9b
End-of-day close multiplied by current shares on issue.
How the market price compares with recent earnings and cash-flow inputs.
P/E
52.3x
Recent market cap compared with trailing earnings.
EPS
0.16
Recent filing-derived earnings per share.
PEG
Not available
Not meaningful without positive comparable earnings growth.
EV/EBITDA
18.13x
Enterprise value compared with recent EBITDA.
P/FCF
99.57x
Market cap compared with recent free cash flow.
P/B
5.54x
Market value compared with latest reported equity.
Yield and fund-style valuation where the company shape supports it.
Dividend yield
7.9%
Trailing dividends compared with the latest close.
Total return
Not available
Available once dividend and adjustment data are verified.
Key metrics
FY26 vs FY25
Revenue
$2b
Caveat: metric quality flags apply; use this value with basis context.
EBITDA
$284.4m
Caveat: metric quality flags apply; use this value with basis context.
Net profit after tax
$113.6m
Caveat: metric quality flags apply; use this value with basis context.
Net cash inflow from operating activities
$133.1m
Caveat: metric quality flags apply; use this value with basis context.
Full-year dividend per share
21.0c
Caveat: metric quality flags apply; use this value with basis context.
Cash and cash equivalents
$784.5m
-28.7% ↓ vs $1.1b
Total assets
$2b
Caveat: metric quality flags apply; use this value with basis context.
Analysis ofATM FY26Result releasedAnnolyse analysis published
What changed
The drag came from a working-capital build of $148.5m (owed capital moving from $200.9m to $349.4m), driven by inventory days nearly doubling to 53.7 from 26.7.
Revenue grew 4.0% to $2b and profit before tax rose 2.5% to $296.6m, but NPAT fell 44.0% to $113.6m, largely reflecting a $96.4m after-tax loss from a discontinued operation against profit from continuing operations of $207.5m. Total equity fell 25.0% to $1.1b, gross borrowings moved to zero from $77.8m, and cash fell 28.7% to $784.5m.
What matters
Acquisition adds balance-sheet context, with NZ$281m acquisition price, but borrowings and gearing are the direct leverage evidence.
OCF/EBITDA at 46.8%, down from 73.4%, combined with inventory days climbing to 53.7 from 26.7, means reported profit growth is not yet being matched by cash generation; this matters because a business funding more stock without a proportional cash release faces tighter near-term liquidity if sell-through slows.
PBT, not NPAT, is the cleaner operating read. PBT growth of 2.5% reflects underlying trading, while the 44.0% NPAT decline is explained by the discontinued-operation loss rather than a tax problem: the effective tax rate actually improved to 30.0% from 33.6%. Continuing-operations profit of $207.5m versus $202.9m prior shows the core business modestly ahead.
Balance sheet moved from net-debt-free to cash-funded distributions. Gross borrowings fell to zero and cash dropped 28.7% to $784.5m, while equity fell 25.0% and ROE weakened to 10.6% from 14.2%. The full-year dividend rose to 21.0 cents per share from 20.0 cents, though the final component fell to 9.5 cents from 11.5 cents, so headline balance-sheet strength has been partly used to fund shareholder returns rather than purely retained.
Expectations
First-half NPAT of $10.9m represented just 9.6% of full-year NPAT of $113.6m, implying a much stronger second half of roughly $102.7m, even though management has flagged supply-chain cost pressure affecting second-half sales and earnings.
This matters because the release does not support a clean read on whether the strong second-half NPAT recovery reflects durable operating momentum or timing effects tied to the discontinued-operation accounting and working-capital build, and there is no disclosed target against which to test forward delivery.
Quality of result
Part of the result looks durable: revenue and PBT growth, plus a modest gain in continuing-operations profit to $207.5m, point to genuine trading improvement, and the effective tax rate improved rather than flattered results artificially. However, a meaningful share of the year's cash position is not durable in the same sense — free cash flow to NPAT conversion fell to 52.5% from 97.5%, and capex-to-revenue rose to 3.7% from 0.2% as investment ramped up, both consistent with cash being absorbed into working capital and capital spending rather than distributed.
The move to zero gross borrowings and a still-substantial $784.5m cash balance suggest financial flexibility remains intact, but the 25.0% fall in equity and the payout ratio of 73.4% against NPAT indicate that balance-sheet strength has been actively deployed rather than simply preserved, which changes how sustainable current distribution levels are if cash conversion does not recover.
Unresolved
This briefing cannot assess whether the implied second-half NPAT strength reflects underlying demand recovery or one-off timing effects, since no segment-level quarterly cash-flow detail or FY27 guidance was disclosed.
Chat
Ask follow-up questions about The a2 Milk Company's FY26 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
FY26 Annual Report
FY26 / financial reportFY26 Results media release
FY26 / media releaseFY26 Results presentation
FY26 / results presentationNZX Results Announcement
FY26 / results announcementFY25 Annual Report
FY25 / financial reportFY25 Results & Supply Chain Transformation update media release
FY25 / media releaseFY25 Results & Supply Chain Transformation update presentation
FY25 / results presentationNZX Results Announcement
FY25 / results announcementInterim Report
HY26 / financial reportMedia Release
HY26 / media releaseNZX Results Announcement
HY26 / results announcementPresentation
HY26 / results presentationFY25 Results Announcement Date and Webcast Notification
FY25 / commentaryFY26 Results Announcement Date and Webcast Notification
FY26 / commentaryTrading, Supply Chain and Outlook Update
FY26 / commentaryAnnual Meeting Presentation
HY26 / commentaryThe a2 Milk Company upgrades FY26 revenue guidance
HY26 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Cash conversion quality
This result converted 46.8% of EBITDA to operating cash flow, -26.6pp versus the prior comparable period.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 46.5pp.
Leverage and balance-sheet risk
Net debt / EBITDA is -2.76x, +0.97x versus the prior comparable period.
Working-capital pressure
Inventory days were 54 days, +27 days versus the prior comparable period.
Get the next The a2 Milk Company briefing and related NZX reporting-season updates by email.